MC2418A1 - Procédé de préparation d'un acide (-) - (3R)-3-méthyl-4-[4-[4- (4-pyridyl) pipérazine-1-yl] phénoxy]butyrique et d'une composition pharmaceutique le contenant - Google Patents
Procédé de préparation d'un acide (-) - (3R)-3-méthyl-4-[4-[4- (4-pyridyl) pipérazine-1-yl] phénoxy]butyrique et d'une composition pharmaceutique le contenantInfo
- Publication number
- MC2418A1 MC2418A1 MC2347A MC2347A MC2418A1 MC 2418 A1 MC2418 A1 MC 2418A1 MC 2347 A MC2347 A MC 2347A MC 2347 A MC2347 A MC 2347A MC 2418 A1 MC2418 A1 MC 2418A1
- Authority
- MC
- Monaco
- Prior art keywords
- piperazine
- phenoxy
- pyridyl
- methyl
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/457,538 US5652242A (en) | 1993-03-29 | 1995-06-01 | Heterocyclic derivatives |
GBGB9518188.9A GB9518188D0 (en) | 1995-09-07 | 1995-09-07 | Optically active derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
MC2418A1 true MC2418A1 (fr) | 1997-05-23 |
Family
ID=26307696
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MC2347A MC2418A1 (fr) | 1995-06-01 | 1996-05-29 | Procédé de préparation d'un acide (-) - (3R)-3-méthyl-4-[4-[4- (4-pyridyl) pipérazine-1-yl] phénoxy]butyrique et d'une composition pharmaceutique le contenant |
Country Status (31)
Country | Link |
---|---|
EP (1) | EP0796247A1 (ja) |
JP (1) | JP2885941B2 (ja) |
KR (1) | KR100245957B1 (ja) |
AT (1) | AT406675B (ja) |
AU (1) | AU710105B2 (ja) |
BE (1) | BE1009520A5 (ja) |
BR (1) | BR9606409A (ja) |
CA (1) | CA2194397A1 (ja) |
CH (1) | CH691808A5 (ja) |
CZ (1) | CZ26997A3 (ja) |
DE (1) | DE19680509T1 (ja) |
DK (1) | DK10697A (ja) |
ES (1) | ES2137886B1 (ja) |
FI (1) | FI970393A (ja) |
GB (1) | GB2304340B (ja) |
GR (1) | GR1002702B (ja) |
HU (1) | HUP9700274A3 (ja) |
IE (1) | IE960405A1 (ja) |
IL (1) | IL118477A0 (ja) |
IT (1) | IT1290839B1 (ja) |
LU (1) | LU90008B1 (ja) |
MC (1) | MC2418A1 (ja) |
MX (1) | MX9700379A (ja) |
NL (1) | NL1003243C2 (ja) |
NO (1) | NO307460B1 (ja) |
NZ (1) | NZ308597A (ja) |
PL (1) | PL318440A1 (ja) |
SE (1) | SE510812C2 (ja) |
SK (1) | SK13097A3 (ja) |
TR (1) | TR199700020T1 (ja) |
WO (1) | WO1996038416A1 (ja) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0100158A3 (en) * | 1982-07-28 | 1985-03-27 | The Upjohn Company | (3-pyridinyl)heteroalkarylalkanols, alkanoic acids and esters |
GB8609630D0 (en) * | 1986-04-19 | 1986-05-21 | Pfizer Ltd | Anti-arrhythmia agents |
WO1994022834A1 (en) * | 1993-03-29 | 1994-10-13 | Zeneca Limited | Heterocyclic derivatives as platelet aggregation inhibitors |
WO1994022835A2 (en) * | 1993-03-29 | 1994-10-13 | Zeneca Limited | Heterocyclic compounds as platelet aggregation inhibitors |
-
1996
- 1996-05-28 TR TR97/00020T patent/TR199700020T1/xx unknown
- 1996-05-28 KR KR1019970700532A patent/KR100245957B1/ko not_active IP Right Cessation
- 1996-05-28 PL PL96318440A patent/PL318440A1/xx unknown
- 1996-05-28 CA CA002194397A patent/CA2194397A1/en not_active Abandoned
- 1996-05-28 WO PCT/GB1996/001260 patent/WO1996038416A1/en not_active IP Right Cessation
- 1996-05-28 AU AU58272/96A patent/AU710105B2/en not_active Ceased
- 1996-05-28 HU HU9700274A patent/HUP9700274A3/hu unknown
- 1996-05-28 GB GB9627127A patent/GB2304340B/en not_active Expired - Fee Related
- 1996-05-28 NZ NZ308597A patent/NZ308597A/en unknown
- 1996-05-28 ES ES009750006A patent/ES2137886B1/es not_active Expired - Fee Related
- 1996-05-28 JP JP8536281A patent/JP2885941B2/ja not_active Expired - Fee Related
- 1996-05-28 BR BR9606409A patent/BR9606409A/pt not_active Application Discontinuation
- 1996-05-28 CH CH00224/97A patent/CH691808A5/de not_active IP Right Cessation
- 1996-05-28 MX MX9700379A patent/MX9700379A/es unknown
- 1996-05-28 SK SK130-97A patent/SK13097A3/sk unknown
- 1996-05-28 EP EP96919906A patent/EP0796247A1/en not_active Withdrawn
- 1996-05-28 DE DE19680509T patent/DE19680509T1/de not_active Withdrawn
- 1996-05-28 GR GR960100176A patent/GR1002702B/el not_active IP Right Cessation
- 1996-05-28 CZ CZ97269A patent/CZ26997A3/cs unknown
- 1996-05-28 AT AT0900596A patent/AT406675B/de active
- 1996-05-29 MC MC2347A patent/MC2418A1/xx unknown
- 1996-05-30 IL IL11847796A patent/IL118477A0/xx unknown
- 1996-05-31 NL NL1003243A patent/NL1003243C2/xx not_active IP Right Cessation
- 1996-05-31 BE BE9600491A patent/BE1009520A5/fr not_active IP Right Cessation
- 1996-05-31 IT IT96MI001113A patent/IT1290839B1/it active IP Right Grant
- 1996-05-31 IE IE960405A patent/IE960405A1/en not_active IP Right Cessation
-
1997
- 1997-01-22 LU LU90008A patent/LU90008B1/fr active
- 1997-01-24 SE SE9700203A patent/SE510812C2/sv not_active IP Right Cessation
- 1997-01-30 DK DK010697A patent/DK10697A/da not_active Application Discontinuation
- 1997-01-30 FI FI970393A patent/FI970393A/fi unknown
- 1997-01-31 NO NO970437A patent/NO307460B1/no not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DZ2666A1 (fr) | Dérivés d'acide hydroxamique compositions pharmaceutiques les contenant et procédé pour leur préparation. | |
DZ2538A1 (fr) | Tartrate d'un dipeptide substitué procédé pour sa préparation et compositions pharmaceutiques le contenant. | |
MA21749A1 (fr) | Procede de compositions de deodorant contenant certains sels d'acide piroctonique et des parfums. | |
FR2526660B1 (fr) | Procede de traitement thermique d'une fraction de plasma, produit obtenu et composition pharmaceutique le contenant | |
DZ2416A1 (fr) | Dérivés d'acide arylsulfonylhydroxamique procédé pour leur préparation et compositions les contenant. | |
DZ2410A1 (fr) | Dérivés d'acide arylsulfonylaminohydroxamique procédé pour leur préparation et compositions pharmaceutiques | |
DZ2679A1 (fr) | Forme hydratée nouvelle d'un dérivé de thiazolidinedione procédé pour sa préparation et composition pharmaceutique la contenant. | |
MA23834A1 (fr) | Procede de preparation de composes inhibiteurs de l'enzyme lp-pla2 et de compositions pharmaceutiques les contenant | |
HUP9603237A3 (en) | Crystalline hydrochloride of (r)-(-)-2-{n-[4-(1,1-dioxydo-3-oxo-2,3-dihydro-benzisothiazo-2-yl)-butyl]-amino-methyl}-chromane, process for the preparation thereof and pharmaceutical compositions containing them | |
AU5778090A (en) | 11B-aryl-4-estrenes, process for their preparation as well as their use as pharmaceutical agents | |
MX9804226A (es) | Derivados novedosos de 2,3,5-trimetil-4-hidroxianilida, su preparacion y su aplicacion de terapeutica. | |
DZ2680A1 (fr) | Dérivé de thiazolidinedione nouveau procédé pour sa préparation et composition pharmaceutique le contenant. | |
HU912486D0 (en) | Process for producing ethers and thioethers of piperidyl | |
FR2569702B1 (fr) | Nouvelle 4'-deschlororebeccamycine, composition pharmaceutique la contenant et procede pour sa preparation | |
PT86635A (pt) | Process for the preparation of novel 4-aryl-n-]2-(dialkylamino and heterocyclicamino)-alkyl"-1-piperazinecarboxamides and of pharmaceutical compositions containing the same | |
TNSN97125A1 (fr) | Composes furanne-nitrone | |
IT8722544A0 (it) | Eparan solfato caratterizzato da elevata attivita' antitrombotica elevata biodisponibilita' assenza di attivita' anticoagulante; suo processo di estrazione da organi e da tessuti e relative composizioni farmaceutiche | |
MC2418A1 (fr) | Procédé de préparation d'un acide (-) - (3R)-3-méthyl-4-[4-[4- (4-pyridyl) pipérazine-1-yl] phénoxy]butyrique et d'une composition pharmaceutique le contenant | |
FR2739292B1 (fr) | Composition pharmaceutique utile pour la transfection d'acides nucleiques et ses utilisations | |
BE1002239A5 (fr) | Solution pharmaceutique. | |
FI884611A (fi) | Menetelmä -/4-(1,1-dimetyylietyyli)fenyyli/-4-(hydroksidifenyylimetyyli)-1-piperidiinibutanolin farmaseuttisen koostumuksen valmistamiseksi | |
GEP20022794B (en) | E-2-[4-(4-Chloro-1,2-Diphenyl-But-1-Enyl)Phenoxy]Ethanol And Pharmaceutical Compositions Thereof | |
FR2730163B1 (fr) | Nouvelle composition pharmaceutique contenant la trimebutine et son procede de preparation | |
IL84521A0 (en) | Salts of(3s(z))-2-(((1-(2-amino-4-thiazolyl)-2-((2,2-dimethyl-4-oxo-1-(sulfooxy)-3-azetidinyl)-amino)-2-oxoethylidene)-amino)oxy)acetic acid,process for the preparation thereof and pharmaceutical compositions containing the same | |
FR2761679B1 (fr) | Procede pour l'elimination d'acides sulfureux residuaires de traitement industriel et pour l'obtention de produits stables |